Arch Venture Fund XII, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 23/09/29

Trade details

Type: Insider buy
Amount: $219,943.46
Shares · price: 16,841 sh · $13.06 a share
Held after: 3,800,228 sh
Stock: Neumora Therapeutics NMRA
Person: Arch Venture Fund XII10% Owner
Trade date: 23/09/28
Filed: 23/09/29
Days to filing: 1 days

7 insiders bought this week

Insiders buying this week: 7 insiders
Holding change: +0.4%

Neumora Therapeutics trades, last 26 weeks

What else happened in Neumora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/29~23/10/28

Arch Venture Fund XII's recent trades

Arch Venture Fund XII10% Owner
BuySeaport Therapeutics
Buy
Seaport Therapeutics
SPTX
$19.8M
1,100,000 sh
$19.8M
Filed 05/04
Traded 05/04
Arch Venture Fund XII10% Owner
BuyNeumora Therapeutics
Buy
Neumora Therapeutics
NMRA
$5M
1,915,700 sh
$5M
Filed 25/10/29
Traded 25/10/27
Arch Venture Fund XII10% Owner
BuyPrime Medicine
Buy
Prime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
Arch Venture Fund XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$25.8M
1,432,224 sh
$25.8M
Filed 25/02/03
Traded 25/02/03
Arch Venture Fund XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$14.2M
789,998 sh
$14.2M
Filed 25/02/03
Traded 25/02/03